查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1878969

神經刺激設備市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、地區和競爭格局分類，2020-2030年預測

Neurostimulation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球神經刺激設備市場規模為60.7億美元，預計2030年將以12.10%的複合年成長率成長至120.5億美元。神經刺激設備是一種特殊的醫療技術，它透過向目標神經或神經通路傳遞可控的電脈衝來調節神經系統內的活動，從而為各種慢性疾病提供治療干預。該市場的主要驅動力是全球神經系統疾病和慢性疼痛的盛行率不斷上升，以及全球人口老化加劇了此類疾病的易感性。此外，患者和臨床醫生越來越傾向於選擇微創治療方案而非傳統的藥物治療方法，也進一步推動了該市場的發展。

市場概覽
預測期 2026-2030
2024年市場規模 60.7億美元
2030年市場規模 120.5億美元
2025-2030年複合年成長率 12.1%
成長最快的細分市場 疼痛管理
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球神經刺激設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（脊髓刺激器、深部腦部刺激器、薦神經刺激器、迷走神經刺激器、其他）
    • 依應用領域（疼痛管理、聽力喪失、尿失禁、帕金森氏症、癲癇、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美神經刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲神經刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區神經刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲神經刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲神經刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球神經刺激設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Boston Scientific Corporation
  • Medtronic PLC
  • Abbott Laboratories Inc.
  • Nevro Corp.
  • Liva Nova PLC
  • Axonics Modulation Technologies Inc.
  • Neuropace Inc.
  • EndoStim Inc.
  • NDI Medical LLC
  • Neuronetics Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 4959

The Global Neurostimulation Devices Market, valued at USD 6.07 Billion in 2024, is projected to experience a CAGR of 12.10% to reach USD 12.05 Billion by 2030. Neurostimulation devices are specialized medical technologies that deliver controlled electrical impulses to targeted nerves or neural pathways to modulate activity within the nervous system, offering therapeutic intervention for various chronic conditions. This market is fundamentally driven by the escalating global prevalence of neurological disorders and chronic pain conditions, coupled with an aging worldwide population more susceptible to such ailments. Further impetus comes from the increasing patient and clinician preference for minimally invasive treatment alternatives over conventional pharmacological approaches.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.07 Billion
Market Size 2030USD 12.05 Billion
CAGR 2025-203012.1%
Fastest Growing SegmentPain Management
Largest MarketNorth America

Key Market Drivers

The rising burden of neurological and chronic pain disorders significantly drives the global neurostimulation devices market. An escalating number of individuals afflicted with conditions such as neuropathic pain, epilepsy, and movement disorders creates a substantial and growing patient population requiring advanced therapeutic interventions. Neurostimulation offers a viable alternative or adjunct to pharmacological treatments, which may have efficacy limitations. According to "A global study of pain prevalence across 52 countries: examining the role of country-level contextual factors," published in the journal BMC Public Health in September 2023, the overall unweighted prevalence of reported pain for the total combined sample was 28%. This high disease burden necessitates effective and durable treatment options, directly stimulating the adoption and development of neurostimulation technologies.

Key Market Challenges

The substantial cost associated with neurostimulation devices and their implantation procedures, alongside complex reimbursement landscapes, represents a significant challenging factor. This financial barrier directly hampers the growth of the Global Neurostimulation Devices Market by limiting patient access and adoption. High upfront expenses for both the devices and the specialized surgical procedures render these therapies inaccessible for many individuals and strain healthcare budgets globally.

Key Market Trends

Advanced miniaturization and wireless connectivity are significantly influencing the Global Neurostimulation Devices Market by enhancing patient comfort and discretion. Smaller implants and wireless features reduce invasive procedures and simplify remote management, fostering long-term therapy adherence. This innovative momentum is substantial across medical technology; MedTech Europe reported over 15,700 patent applications filed with the European Patent Office in medical technology in 2024, reflecting sustained growth in device advancements.

Key Market Players

  • Boston Scientific Corporation
  • Medtronic PLC
  • Abbott Laboratories Inc.
  • Nevro Corp.
  • Liva Nova PLC
  • Axonics Modulation Technologies Inc.
  • Neuropace Inc.
  • EndoStim Inc.
  • NDI Medical LLC
  • Neuronetics Inc

Report Scope:

In this report, the Global Neurostimulation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neurostimulation Devices Market, By Type:

  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others

Neurostimulation Devices Market, By Application:

  • Pain Management
  • Hearing Loss
  • Urinary Incontinence
  • Parkinson's Disease
  • Epilepsy
  • Others

Neurostimulation Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Neurostimulation Devices Market.

Available Customizations:

Global Neurostimulation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Neurostimulation Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Others)
    • 5.2.2. By Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Neurostimulation Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Neurostimulation Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Neurostimulation Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Neurostimulation Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Neurostimulation Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Neurostimulation Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Neurostimulation Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Neurostimulation Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Neurostimulation Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Neurostimulation Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Neurostimulation Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Neurostimulation Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Neurostimulation Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Neurostimulation Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Neurostimulation Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Neurostimulation Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Neurostimulation Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Neurostimulation Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Neurostimulation Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Neurostimulation Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Neurostimulation Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Neurostimulation Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Neurostimulation Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Neurostimulation Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Neurostimulation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boston Scientific Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Medtronic PLC
  • 15.3. Abbott Laboratories Inc.
  • 15.4. Nevro Corp.
  • 15.5. Liva Nova PLC
  • 15.6. Axonics Modulation Technologies Inc.
  • 15.7. Neuropace Inc.
  • 15.8. EndoStim Inc.
  • 15.9. NDI Medical LLC
  • 15.10. Neuronetics Inc.

16. Strategic Recommendations

17. About Us & Disclaimer